Asset Publisher

Back Scott Ohanesian: Life science logistics in a life-changing world | Clinical Trial & Cold Chain Logistics

In this episode, host Chris Riback speaks with QuickSTAT’s Scott Ohanesian, Senior VP of Commercial Operations, North America. This program was recorded on April 27th, 2020, as the COVID-19 crisis was continuing its dramatic impact on lives globally....


Download transcript


In this episode, host Chris Riback speaks with QuickSTAT’s Scott Ohanesian, Senior VP of Commercial Operations, North America. This program was recorded on April 27th, 2020, as the COVID-19 crisis is continuing its dramatic impact on lives globally. But in the life science space, even during a pandemic, patients who are being treated for non-COVID-19 illnesses still need to receive their treatments. Clinical trials must move forward. And medical supply chains have to be kept intact. What’s more, while the virus rages, many companies around the world have quickly switched their focus to the development of a COVID-19 vaccine. The usually fast-paced world of life science logistics is now moving even faster. Scott, who has spent the last 15 years managing global logistics for Phase 1 to Phase IV clinical trials, shares how QuickSTAT has been meeting the challenges faced by pharma and biotech clients since the onset of the current healthcare crisis. Scott shares:

 
  • What goes into supporting logistics for clinical trials when confronted by so many pandemic-created obstacles.
  • The solutions and services that help companies adhere to trial protocols, keep patients safe and ensure that their therapies are received on time.
  • Best logistics practices for overcoming an array of challenges -- including government regulations, severely reduced airline schedules and dire economic situations.

As Scott tells Chris, “It’s not just about moving a box or a package. There’s somebody at the end of that it’s going to have an impact on.” And you’ll hear in this episode just how that patient-centered approach is at the heart of what Scott and the QuickSTAT team delivers – an approach that is even more critical than ever.